Abstract
The eukaryotic translation initiation factor eIF4E is dysregulated in many cancers. eIF4E, through its mRNA export and translation functions, combinatorially modulates the expression of genes involved in Akt dependent survival signaling. For these activities, eIF4E must bind the 7-methyl guanosine (m(7)G) cap moiety on the 5'-end of mRNAs. We demonstrate that a physical mimic of the m(7)G cap, ribavirin, inhibits eIF4E dependent Akt survival signaling. Specifically, ribavirin impairs eIF4E mediated Akt activation via inhibiting the production of an upstream activator of Akt, NBS1. Consequently, ribavirin impairs eIF4E dependent apoptotic rescue. A ribavirin analog with distinct physico-chemical properties, tiazofurin, does not impair eIF4E activity indicating that only analogs that mimic the m(7)G cap will inhibit eIF4E function. Ribavirin represents a first-in-class strategy to inhibit eIF4E dependent cancers, through competition for m(7)G cap binding. Thus, ribavirin coordinately impairs eIF4E dependent pathways and thereby, potently inhibits its biological effects.
References
Jan 1, 1985·Journal of Medicinal Chemistry·G GebeyehuD G Johns
Jul 1, 1986·Antimicrobial Agents and Chemotherapy·D F Smee, T R Matthews
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·D RousseauN Sonenberg
Nov 1, 1996·Molecular and Cellular Biology·V A PolunovskyP B Bitterman
Apr 30, 1998·Current Opinion in Cell Biology·N Sonenberg, A C Gingras
Jun 14, 2000·The Laryngoscope·R J DeFattaA De Benedetti
May 28, 2003·Cancer Letters·M ColovicP Milenkovic
Oct 3, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra R KnowlesLarissa Matukas
Dec 3, 2003·Molecular and Cellular Biology·Ivan TopisirovicKatherine L B Borden
Mar 19, 2004·Nature·Hans-Guido WendelScott W Lowe
Sep 24, 2004·Leukemia Research·Karim MalekDaniel G Wright
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alex KentsisKatherine L B Borden
Apr 20, 2005·The Journal of Cell Biology·Biljana CuljkovicKatherine L B Borden
Oct 26, 2005·Cell Biology International·Revekka HarisiAndrás Jeney
Oct 28, 2005·RNA·Alex KentsisKatherine L B Borden
Nov 1, 2006·The Journal of Cell Biology·Biljana CuljkovicKatherine L B Borden
Jan 25, 2007·Cell Cycle·Biljana CuljkovicKatherine L B Borden
Feb 22, 2007·PloS One·Yaël MamaneNahum Sonenberg
Jun 19, 2007·Nature Reviews. Genetics·Jack D Keene
Sep 6, 2007·The Journal of Clinical Investigation·Jeremy R GraffEric G Marcusson
Feb 14, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yen-Chung ChenKou-Juey Wu
Mar 11, 2008·Breast Cancer Research and Treatment·Ke DongHui-Zhong Zhang
Apr 9, 2008·The Journal of Cell Biology·Biljana CuljkovicKatherine L B Borden
Citations
Mar 12, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Martin Carroll, Katherine L B Borden
Mar 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Filippa PetterssonWilson H Miller
May 13, 2009·Blood·Sarit AssoulineKatherine L B Borden
Jan 6, 2010·Journal of Oncology·Biljana Culjkovic, Katherine L Borden
Jul 16, 2010·Leukemia & Lymphoma·Katherine L B Borden, Biljana Culjkovic-Kraljacic
Jan 19, 2016·Expert Reviews in Molecular Medicine·Chunwan LuYafei Cai
Mar 24, 2012·Current Opinion in Virology·Jan PaeshuyseJohan Neyts
Oct 30, 2013·Basic & Clinical Pharmacology & Toxicology·Gergely OswaldFlorian Lang
Dec 17, 2014·Immunological Reviews·Michael J Osborne, Katherine L B Borden
Jul 10, 2014·Expert Opinion on Therapeutic Targets·Filippa PetterssonWilson H Miller
Oct 23, 2010·Bioscience Reports·Ji-Ye YinJian-Ting Zhang
Nov 26, 2014·International Journal of Oncology·Victoria ZismanovLiat Drucker
Sep 19, 2012·Antiviral Research·Lan-Juan ZhaoZhong-Tian Qi
Jul 21, 2010·Blood·Sumaiya SharmeenAaron D Schimmer
Sep 1, 2015·PloS One·Fangfang ShiTianyou Yan
Aug 9, 2016·Laboratory Investigation; a Journal of Technical Methods and Pathology·Oshrat Attar-SchneiderMaya Gottfried
Nov 1, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J CaoD Chen
Nov 28, 2018·Oncogene·Karen A UrtishakCarolyn A Felix
Dec 12, 2019·PloS One·Anaïs WambeckeFranck Carreiras
Dec 2, 2010·Biochemical Society Transactions·Ernesto Yagüe, Selina Raguz
Nov 8, 2017·Journal of Biochemical and Molecular Toxicology·Jun TanYaoren Hu
Jan 1, 2014·Cancer Cell International·Lichen TengRuihua An
Nov 7, 2019·Frontiers in Physiology·Li LinWei Han
Nov 6, 2018·Viruses·Hui-Jun DongXiao-Jia Wang
Jan 23, 2015·Cancer Research·Filippa PetterssonWilson H Miller
Mar 9, 2012·Cancer Research·Thomas J HaymanPhilip J Tofilon
Jul 3, 2019·Molecular Cancer Therapeutics·Joshua CasaosNicolas Skuli
Oct 17, 2019·Cold Spring Harbor Perspectives in Medicine·Camila Prieto, Michael G Kharas
Dec 8, 2020·Biochemistry. Biokhimii︠a︡·S E DmitrievK A Lashkevich
Feb 12, 2019·Biochemical and Biophysical Research Communications·Jing JinAli Deng
Jul 3, 2021·Cancers·Christina PfabNahed El-Najjar